Literature DB >> 31519495

Symptom progression in advanced Parkinson's disease: Dyadic perspectives.

Melanie A Horning1, Ju Young Shin2, Leigh Ann DiFusco1, Michelle Norton1, Barbara Habermann3.   

Abstract

This qualitative descriptive study investigated the self-reported symptoms of people with advanced Parkinson's disease. Fifteen dyads (person with Parkinson's and family caregiver) participated in two semi-structured interviews over a six-month time period; content analysis was used to explore the progression and new onset of symptoms. Reported symptoms in descending order included gait deterioration, falls, speech impairment, cognitive decline, functional decline, gastrointestinal and genitourinary changes, and swallowing impairment. The presence of multiple, compounding symptoms present challenges for maintaining safety in the home, highlighting the need for in-home services to assist with symptom management. Change in self-reported symptom experience was not significantly different after a six-month time frame. Symptom progression in advanced Parkinson's disease may take longer than six months to appreciatively manifest. Therefore, future research should explore the progression of advanced Parkinson's disease longitudinally over of period of time that exceeds six months.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced Parkinson's disease; Changes; Dyads; Symptoms

Year:  2019        PMID: 31519495     DOI: 10.1016/j.apnr.2019.151193

Source DB:  PubMed          Journal:  Appl Nurs Res        ISSN: 0897-1897            Impact factor:   2.257


  2 in total

1.  The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.

Authors:  Chellappan Praveen Rajneesh; Jian-Chiun Liou; Tsung-Hsun Hsieh; Jia-Hong Lin; Chih-Wei Peng
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

2.  Gradient boosting for Parkinson's disease diagnosis from voice recordings.

Authors:  Ibrahim Karabayir; Samuel M Goldman; Suguna Pappu; Oguz Akbilgic
Journal:  BMC Med Inform Decis Mak       Date:  2020-09-15       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.